The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Open accessAbstract
Most normal mammalian cells have a finite lifespan, thought to constitute a protective mechanism against unlimited proliferation. This phenomenon, called senescence, is driven by telomere attrition, which triggers the induction of tumour suppressors including p16(INK4a) (ref. 5). In cultured cells, senescence can be elicited prematurely by oncogenes; however, whether such oncogene-induced senescence represents a physiological process has long been debated. Human naevi (moles) are benign tumours of melanocytes that frequently harbour oncogenic mutations (predominantly V600E, where valine is substituted for glutamic acid) in BRAF, a protein kinase and downstream effector of Ras. Nonetheless, naevi typically remain in a growth-arrested state for decades and only rarely progress into malignancy (melanoma). This raises the question of whether naevi undergo BRAF(V600E)-induced senescence. Here we show that sustained BRAF(V600E) expression in human melanocytes induces cell cycle arrest, which is accompanied by the induction of both p16(INK4a) and senescence-associated acidic beta-galactosidase (SA-beta-Gal) activity, a commonly used senescence marker. Validating these results in vivo, congenital naevi are invariably positive for SA-beta-Gal, demonstrating the presence of this classical senescence-associated marker in a largely growth-arrested, neoplastic human lesion. In growth-arrested melanocytes, both in vitro and in situ, we observed a marked mosaic induction of p16(INK4a), suggesting that factors other than p16(INK4a) contribute to protection against BRAF(V600E)-driven proliferation. Naevi do not appear to suffer from telomere attrition, arguing in favour of an active oncogene-driven senescence process, rather than a loss of replicative potential. Thus, both in vitro and in vivo, BRAF(V600E)-expressing melanocytes display classical hallmarks of senescence, suggesting that oncogene-induced senescence represents a genuine protective physiological process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, the BRAF oncogenic mutation found in more than half of all malignant cutaneous melanomas is commonly found also in non-malignant nevi, where it causes oncogene-induced senescence exemplified by high levels of CDKN2A and SA-β-gal expression225–227.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [225]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse models of melanoma and human nevi (both oncogene driven) show accumulation of SA-β-gal+–CDKN2A+ foci224,225.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [225]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hallmarks of senescent cells were subsequently identified in dermal premalignant lesions, specifically human melanocytic naevi 81,82 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [81]
In the citing paper
“Oncogene-induced senescence protects against tumor initiation 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [35]
In the citing paper
“OIS is a powerful tumor suppressor mechanism 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [35]
In the citing paper
“in vitro experiments showed that cells that lack functional p53 or overexpress the H3K9me3 demethylase JMJD2c46,50 — which therefore cannot enter senescence in response to pro-senescent oncogenes such as Ras-G12V or Braf-V600E46,51 — also failed to enter VIS and lacked a SASP upon infection with SARS-CoV-2 (ref.28).”
From COVID-19 and cellular senescence (2023) · cites this paper as [51]
In the citing paper
“Studies have demonstrated high levels of senescence in premalignant lesions and lower levels in invasive disease, suggesting a role for senescence in blocking malignant progression [2,31,32].”
From Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies (2020) · cites this paper as [32]
In the citing paper
“human melanocytic naevi (an OIS model), remain non-proliferative for decades without transformation into malignant melanoma 25”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [25]
In the citing paper
“This is a seminal study that identified OIS of human melanocytic naevi.”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [25]
In the citing paper
“Senescence markers are detected in premalignant tumor lesions but not at later stages of tumor development [17,18,19].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Benign melanocytic lesions, which are melanoma precursors in humans, express high p16 and are an in vivo example of OIS [19,55].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Indeed, such telomeres are not visibly shorter than functional telomeres [114] in human melanocytic nevi with frequent BRAF mutations, a typical OIS feature in vivo [19].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Indeed, its locus is more commonly deleted or silenced than mutated in melanoma, the more malignant later stage of disease [19,55].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“For example, N-RAS- or B-RAF-activating mutations are commonly found in benign melanocytic nevi that show features of senescence, such as elevated p16 levels, but that do not express appreciable levels of ARF or p53 [19,55].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“In humans, Ras activation appears to induce only p16 [19,127].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“senescence occurs during the formation of benign cutaneous melanocytic nevi that express an oncogenic form of BRAF [19].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Importantly, this work also provided evidence for the occurrence of 4N senescent cells in human melanocyte naevi, the first in vivo senescence model, 94 suggesting that the G2 exit program has a more general role in senescence.”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [94]
In the citing paper
“The acronym oncogene-induced senescence (OIS) was coined following the demonstration that the aberrant activation of oncogenes (e.g., Ras, BRAF V600E, and c-Myc) or loss of tumor suppressor genes (e.g., PTEN) temporarily arrests a large variety of tumors in a pre-malignant state 180-183 (Figure 3B).”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [182]
In the citing paper
“BRAFV600E mutation alone is often insufficient to drive malignant transformation of melanocytes24.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [24]
In the citing paper
“For example, developmental senescent cells express p21WAF1/Cip1 but not p16INK4a9,10, while the reverse is observed in melanocytic nevi36,37.”
From Algorithmic assessment of cellular senescence in experimental and clinical specimens (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
Lowe, S. W., Cepero, E., & Evan, G. I. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,374
Flagged first, then by citations
Research works printed but not linked: 1
- Peeper, D. S. & Mooi, W. J. Pathogenesis of melanocytic naevi: growth arrest linked with cellular senescence? Histopathology 41, S139–S143 (2002)
Cited by
Sorted by citations
Items 401–500 of 1,009
Back to the roots: the remarkable RAF oncogene story
Zebisch, A., & Troppmair, J. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6005-y · Cited by 127
Oncogene-induced Cellular Senescence
Chandeck, C., & Mooi, W. J. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181c66f4e · Cited by 127
Self-citationAblation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor
Neault, M., Mallette, F. A., Vogel, G., Michaud‐Levesque, J., & Richard, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks764 · Cited by 126
mTOR Signaling from Cellular Senescence to Organismal Aging
Xu, S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500263 · Cited by 125
Bataille, V. A., Kato, B. S., Falchi, M., Gardner, J. P., Kimura, M., Lens, M. B., Perks, U., Valdes, A. M., Bennett, D. C., Aviv, A., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0152 · Cited by 125
Mallette, F. A., & Richard, S. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.033 · Cited by 125
The role of Stat5 transcription factors as tumor suppressors or oncogenes
Ferbeyre, G., & Moriggl, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.004 · Cited by 124
Regulation of cellular senescence via the FOXO 4‐p53 axis
Bourgeois, B. M. R., & Madl, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13057 · Cited by 124
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 125
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Xie, W., Kagiampakis, I., Pan, L., Zhang, Y. W., Murphy, L., Tao, Y., Kong, X., Kang, B., Xia, L., Carvalho, F. L. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.008 · Cited by 122
Role of the autotaxin–lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy
Brindley, D. N., Lin, F., & Tigyi, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.015 · Cited by 122
Lin, J., Goto, Y., Murata, H., Sakaizawa, K., Uchiyama, A., Saida, T., & Takata, M. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606072 · Cited by 122
Leontieva, O. V., & Blagosklonny, M. V. (2013) · Cell Cycle · doi:10.4161/cc.26130 · Cited by 122
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 125
BRAF Mutations in Metanephric Adenoma of the Kidney
Choueiri, T. K., Cheville, J. C., Palescandolo, E., Fay, A. P., Kantoff, P. W., Atkins, M. B., McKenney, J. K., Brown, V. E., Lampron, M. E., Zhou, M., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.051 · Cited by 121
Lafferty‐Whyte, K., Cairney, C. J., Jamieson, N. B., Oien, K. A., & Keith, W. N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.003 · Cited by 120
STAT3 and STAT5 Activation in Solid Cancers
Igelmann, S., Neubauer, H. A., & Ferbeyre, G. (2019) · Cancers · doi:10.3390/cancers11101428 · Cited by 120
Tront, J. S., Hoffman‐Liebermann, B., & Liebermann, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2013 · Cited by 120
Lau, L., Porciuncula, A., Yu, A., Iwakura, Y., & David, G. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00586-18 · Cited by 119
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
Durham, B. H., Getta, B. M., Dietrich, S., Taylor, J., Won, H. H., Bogenberger, J. M., Scott, S. N., Kim, E. H., Chung, Y. R., Chung, S. S., et al. (2017) · Blood · doi:10.1182/blood-2017-01-765107 · Cited by 119
Lunyak, V. V., Amaro-Ortiz, A., & Gaur, M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00220 · Cited by 119
Cellular senescence: Its role in tumor suppression and aging
Ohtani, N., Mann, D. J., & Hara, E. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01123.x · Cited by 119
Senescence-Associated Oxidative DNA Damage Promotes the Generation of Neoplastic Cells
Gosselin, K., Martien, S., Pourtier, A., Vercamer, C., Ostoich, P. V., Morat, L., Sabatier, L., Duprez, L., de Roodenbeke, C. T., Gilson, É., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2510 · Cited by 119
Flaherty, K. T., & McArthur, G. A. (2010) · Cancer · doi:10.1002/cncr.25261 · Cited by 118
Iwanaga, K., Yang, Y., Raso, M. G., Ma, L., Hanna, A. E., Thilaganathan, N., Moghaddam, S. J., Evans, C. M., Li, H., Cai, W., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3117 · Cited by 118
Cellular senescence predicts treatment outcome in metastasised colorectal cancer
Haugstetter, A. M., Loddenkemper, C., Lenze, D., Gröne, J., Standfuß, C., Petersen, I., Dörken, B., & Schmitt, C. A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605784 · Cited by 117
The emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 117
Oncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
Vemurafenib Induces Senescence Features in Melanoma Cells
Haferkamp, S., Borst, A., Adam, C., Becker, T. M., Motschenbacher, S., Windhövel, S., Hufnagel, A., Houben, R., & Meierjohann, S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.6 · Cited by 116
BRAF somatic mutations in malignant melanoma and melanocytic naevi
Thomas, N. E. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000215035.38436.87 · Cited by 116
Recent advances in the understanding of Langerhans cell histiocytosis
Badalian‐Very, G., Vergilio, J., Degar, B. A., Galindo, C. R., & Rollins, B. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08915.x · Cited by 115
Ostrowski, S. M., & Fisher, D. E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.08.010 · Cited by 115
Leidal, A. M., Cyr, D. P., Hill, R. J., Lee, P. W. K., & McCormick, C. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.005 · Cited by 113
Oikonomou, E., Koustas, E., Goulielmaki, M., & Pintzas, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2555 · Cited by 113
Besancenot, R., Chaligné, R., Tonetti, C., Pasquier, F., Marty, C., Lécluse, Y., Vainchenker, W., Constantinescu, S. N., & Giraudier, S. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000476 · Cited by 113
Cangi, M. G., Biavasco, R., Cavalli, G., Grassini, G., Dal-Cin, E., Campochiaro, C., Guglielmi, B., Berti, A., Lampasona, V., von Deimling, A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204924 · Cited by 112
Vitiligo: A Possible Model of Degenerative Diseases
Bellei, B., Pitisci, A., Ottaviani, M., Ludovici, M., Cota, C., Luzi, F., Dell’Anna, M. L., & Picardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059782 · Cited by 112
The dysplastic nevus: From historical perspective to management in the modern era
Duffy, K. L., & Grossman, D. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.03.013 · Cited by 111
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
D’Ambrosio, M., & Gil, J. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.05.010 · Cited by 111
Recurrent CDKN1B (p27) mutations in hairy cell leukemia
Dietrich, S., Hüllein, J., Lee, S. C.-W., Hutter, B., de Castro, D. G., Jayne, S., Dyer, M. J. S., Oleś, M., Else, M., Liu, X., et al. (2015) · Blood · doi:10.1182/blood-2015-04-643361 · Cited by 111
Swarbrick, A., Roy, E., Allen, T., & Bishop, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801505105 · Cited by 111
Role of ING4 in human melanoma cell migration, invasion and patient survival
Li, J., Martinka, M., & Li, G. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn086 · Cited by 111
Sessile Serrated Adenoma With Early Neoplastic Progression
Fujita, K., Yamamoto, H., Matsumoto, T., Hirahashi, M., Gushima, M., Kishimoto, J., Nishiyama, K., Taguchi, T., Yao, T., & Oda, Y. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318205df36 · Cited by 110
Autophagy and senescence in cancer therapy
Gewirtz, D. A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24420 · Cited by 110
Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis
Shabaneh, T. B., Molodtsov, A. K., Steinberg, S. M., Zhang, P., Torres, G. M., Mohamed, G. A., Boni, A., Curiel, T. J., Angeles, C. V., & Turk, M. J. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0365 · Cited by 110
Detecting and targeting senescent cells using molecularly imprinted nanoparticles
Ekpenyong‐Akiba, A. E., Canfarotta, F., Bashar Abd, H., Poblocka, M., Casulleras, M., Castilla‐Vallmanya, L., Kocsis‐Fodor, G., Kelly, M. E., Janus, J., Althubiti, M., et al. (2019) · Nanoscale Horizons · doi:10.1039/c8nh00473k · Cited by 111
Targeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 113
Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
Palmieri, G., Ombra, M. N., Colombino, M., Casula, M., Sini, M. C., Manca, A., Paliogiannis, P., Ascierto, P. A., & Cossu, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00183 · Cited by 110
ROS ‐generating oxidases N ox1 and N ox4 contribute to oncogenic R as‐induced premature senescence
Kodama, R., Kato, M., Furuta, S., Ueno, S., Zhang, Y., Matsuno, K., Yabe‐Nishimura, C., Tanaka, E., & Kamata, T. (2012) · Genes to Cells · doi:10.1111/gtc.12015 · Cited by 110
Senescent Fibroblasts Enhance Early Skin Carcinogenic Events via a Paracrine MMP-PAR-1 Axis
Malaquin, N., Vercamer, C., Bouali, F., Martien, S., Deruy, E., Wernert, N., Chwastyniak, M., Pinet, F., Abbadie, C., & Pourtier, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063607 · Cited by 110
Focus on cutaneous and uveal melanoma specificitiesPreprint
Pandiani, C., Béranger, G. E., Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Genes & Development · doi:10.1101/gad.296962.117 · Cited by 110
LncRNAs Regulatory Networks in Cellular Senescence
Pavan Kumar, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112615 · Cited by 109
Premature senescence of human endothelial cells induced by inhibition of glutaminase
Unterluggauer, H., Mazurek, S., Lener, B., Hütter, E., EIGENBRODT, E., Zwerschke, W., & Jansen‐Dürr, P. (2008) · Biogerontology · doi:10.1007/s10522-008-9134-x · Cited by 109
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
Nicke, B., Bastien, J., Khanna, S. J., Warne, P. H., Cowling, V., Cook, S. J., Peters, G., Delpuech, O., Schulze, A., Berns, K., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.038 · Cited by 108
MicroRegulators come of age in senescence
Gorospe, M., & Abdelmohsen, K. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.005 · Cited by 108
Penman, C. L., Faulkner, C., Lowis, S. P., & Kurian, K. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00054 · Cited by 107
Suzuki, H., Igarashi, S., Nojima, M., Maruyama, R., Yamamoto, E., Kai, M., Akashi, H., Watanabe, Y., Yamamoto, H., Sasaki, Y., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp179 · Cited by 107
The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies
Toutfaire, M., Bauwens, É., & Debacq‐Chainiaux, F. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.011 · Cited by 107
Aging of the Immune System: Research Challenges to Enhance the Health Span of Older Adults
Haynes, L. (2020) · Frontiers in Aging · doi:10.3389/fragi.2020.602108 · Cited by 106
cGAS-STING signaling in cancer immunity and immunotherapy
Du, H., Xu, T., & Cui, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110972 · Cited by 106
Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths
Smit, M. A., & Peeper, D. S. (2010) · Aging · doi:10.18632/aging.100209 · Cited by 106
Self-citationNelson, D. M., Jaber‐Hijazi, F., Cole, J. J., Robertson, N., Pawlikowski, J. S., Norris, K., Criscione, S. W., Pchelintsev, N. A., Piscitello, D., Stong, N., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1017-x · Cited by 105
Biological functions of therapy-induced senescence in cancer
Fitsiou, E., Soto-Gamez, A., & Demaria, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.021 · Cited by 105
Goding, C. R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.003 · Cited by 105
Liu, Y., Hawkins, O. E., Su, Y., Vilgelm, A. E., Sobolik, T., Thu, Y. M., Kantrow, S. M., Splittgerber, R. C., Short, S. P., Amiri, K. I., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201378 · Cited by 104
Gast, A., Scherer, D., Chen, B., Bloethner, S., Melchert, S., Sucker, A., Hemminki, K., Schadendorf, D., & Kumar, R. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20785 · Cited by 104
Panebianco, C., Oben, J. A., Vinciguerra, M., & Pazienza, V. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0438-x · Cited by 104
Thaler, S., Hähnel, P. S., Schad, A., Dammann, R., & Schüler, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1377 · Cited by 104
Bach1 inhibits oxidative stress–induced cellular senescence by impeding p53 function on chromatin
Dohi, Y., Ikura, T., Hoshikawa, Y., Katoh, Y., Ota, K., Nakanome, A., Muto, A., Omura, S., Ohta, T., Ito, A., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1516 · Cited by 104
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
Molecular pathways of senescence regulate placental structure and function
Gal, H., Lysenko, M., Stroganov, S., Vadai, E., Youssef, S. A., Geffen, K. T., Rotkopf, R., Biron‐Shental, T., de Bruin, A., Neeman, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100849 · Cited by 103
Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma
Kreuger, I. Z. M., Slieker, R. C., van Groningen, T., & van Doorn, R. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.07.016 · Cited by 106
The dysplastic nevus: From historical perspective to management in the modern era
Duffy, K. L., & Grossman, D. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.02.047 · Cited by 103
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer
Caldwell, M. E., DeNicola, G. M., Martins, C. P., Jacobetz, M. A., Maitra, A., Hruban, R. H., & Tuveson, D. A. (2011) · Oncogene · doi:10.1038/onc.2011.350 · Cited by 103
The evolving concept of tumor microenvironments
Laconi, E. (2007) · BioEssays · doi:10.1002/bies.20606 · Cited by 103
Eating to exit: autophagy-enabled senescence revealed: Figure 1.Preprint
White, E., & Lowe, S. W. (2009) · Genes & Development · doi:10.1101/gad.1795309 · Cited by 103
Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity
Guillon, J., Petit, C., Toutain, B., Guette, C., Lelièvre, E., & Coqueret, O. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1652047 · Cited by 102
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Hubáčková, S., Davidová, E., Rohlenová, K., Štursa, J., Werner, L., Anděra, L., Dong, L., Terp, M. G., Hodný, Z., Ditzel, H. J., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0118-3 · Cited by 102
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 102
Conditional ablation of Ikkb inhibits melanoma tumor development in mice
Yang, J., Splittgerber, R. C., Yull, F. E., Kantrow, S. M., Ayers, G. D., Karin, M., & Richmond, A. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42358 · Cited by 102
Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Welford, S. M., & Giaccia, A. J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0065 · Cited by 103
Cellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 101
Li, Y., Cheng, H. S., Chng, W. J., & Tergaonkar, V. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611106113 · Cited by 101
Pitiyage, G. N., Slijepčević, P., Gabrani, A., Chianea, Y. G., Lim, K. P., Prime, S. S., Tilakaratne, W. M., Fortune, F., & Parkinson, E. K. (2010) · The Journal of Pathology · doi:10.1002/path.2839 · Cited by 101
Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control
Takahashi, A., Ohtani, N., & Hara, E. (2007) · Cell Division · doi:10.1186/1747-1028-2-10 · Cited by 101
Pawłowska, E., Szczepańska, J., Szatkowska, M., & Błasiak, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030889 · Cited by 100
Understanding Signaling Cascades in Melanoma†
Lopez‐Bergami, P., Fitchman, B., & Ronai, Z. A. (2007) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00254.x · Cited by 100
Kriegl, L., Neumann, J., Vieth, M., Greten, F. R., Reu, S., Jung, A., & Kirchner, T. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.43 · Cited by 99
FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression
Li, S. K. M., Smith, D. K., Leung, W. Y., Cheung, A. M. S., Lam, E. W. ‐., Dimri, G. P., & Yao, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709604200 · Cited by 99
Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating Oxidative Phosphorylation
Haq, R., Fisher, D. E., & Widlund, H. R. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0898 · Cited by 99
Golde, T. E., & Miller, V. M. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt5 · Cited by 98
Shorter Telomeres Associate with a Reduced Risk of Melanoma Development
Nan, H., Du, M., Vivo, I. D., Manson, J. E., Liu, S., McTiernan, A., Curb, J. D., Lessin, L. S., Bonner, M. R., Guo, Q., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1988 · Cited by 98
A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
Smits, K. M., Paranjape, T., Nallur, S. V., Wouters, K. A. D., Weijenberg, M. P., Schouten, L. J., van den Brandt, P. A., Bosman, F. T., Weidhaas, J. B., & van Engeland, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0990 · Cited by 98
Cellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 99
Connecting autophagy to senescence in pathophysiology
Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 98
Hubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 97
The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
Zinatizadeh, M. R., Miri, S. R., Zarandi, P. K., Chalbatani, G. M., Rapôso, C., Mirzaei, H. R., Akbari, M. E., & Mahmoodzadeh, H. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.11.003 · Cited by 98
The Histone Code of Senescence
Paluvai, H., Giorgio, E. D., & Brancolini, C. (2020) · Cells · doi:10.3390/cells9020466 · Cited by 97
Metadata
- Authors
- Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- University of Michigan (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Mooi, Wolter J.
- Peeper, Daniel S.
- Venue
- Nature
- Published
- 2005-08
- Volume
- 436
- Issue
- 7051
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2150740687
- Semantic Scholar
- bfbf433cb25b4a5e054e35a6850376801a03b87d
- Cited by
- 2,160
- References
- 31
- Citations by year
- 2026: 35 · 2025: 43 · 2024: 70 · 2023: 82 · 2022: 77 · 2021: 85 · 2020: 86 · 2019: 108 · 2018: 99 · 2017: 91 · 2016: 121 · 2015: 112 · 2014: 120 · 2013: 143 · 2012: 136
- FWCI
- 66.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, BRAF V600E mutation, melanocytes, nevi, melanoma, cell cycle arrest, senescence-associated heterochromatin foci, SUV39H1, histone methyltransferase, p16INK4a, p53, PTEN, oncogene-induced senescence, tumor suppression
- MeSH terms
- beta-Galactosidase, Cell Cycle, Cell Line, Fibroblasts, Humans, Infant, Melanocytes, Nevus, Telomere, Cellular Senescence, In Situ Hybridization, Fluorescence, Cyclin-Dependent Kinase Inhibitor p16, Proto-Oncogene Proteins B-raf, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
